J
John R. Geddes
Researcher at University of Oxford
Publications - 469
Citations - 45932
John R. Geddes is an academic researcher from University of Oxford. The author has contributed to research in topics: Bipolar disorder & Mood. The author has an hindex of 83, co-authored 441 publications receiving 37064 citations. Previous affiliations of John R. Geddes include National Health Service & University College London.
Papers
More filters
Journal ArticleDOI
What is a randomised controlled trial
Andrea Cipriani,John R. Geddes +1 more
TL;DR: The Consolidated Statement of Reporting Trials (CONSORT) provides readers of RCTs with a list of criteria useful to assess trial validity (for full details visit www.consortstatement.org).
Journal ArticleDOI
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht,Andrea Cipriani,Andrea Cipriani,Loukia M. Spineli,Dimitris Mavridis,Deniz Örey,Franziska Richter,Myrto Samara,Corrado Barbui,Rolf R. Engel,John R. Geddes,Werner Kissling,Marko Paul Stapf,Bettina Lässig,Georgia Salanti,John M. Davis +15 more
TL;DR: A Bayesian-framework, multiple-treatments meta-analysis of randomised controlled trials to compare 15 antipsychotic drugs and placebo in the acute treatment of schizophrenia found all drugs were significantly more effective than placebo.
Journal ArticleDOI
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Andrea Cipriani,Andrea Cipriani,Toshi A. Furukawa,Georgia Salanti,Anna Chaimani,Anna Chaimani,Anna Chaimani,Lauren Z Atkinson,Lauren Z Atkinson,Yusuke Ogawa,Stefan Leucht,Henricus G. Ruhé,Henricus G. Ruhé,Erick H. Turner,Julian P T Higgins,Matthias Egger,Nozomi Takeshima,Yu Hayasaka,Hissei Imai,Kiyomi Shinohara,Aran Tajika,John P. A. Ioannidis,John R. Geddes,John R. Geddes +23 more
TL;DR: This work aimed to update and expand previous work to compare and rank antidepressants for the acute treatment of adults with unipolar major depressive disorder, and found that all antidepressants were more effective than placebo.
Journal ArticleDOI
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani,Andrea Cipriani,Toshiaki A. Furukawa,Georgia Salanti,John R. Geddes,Julian P T Higgins,Rachel Churchill,Norio Watanabe,Atsuo Nakagawa,Ichiro M Omori,Hugh McGuire,Michele Tansella,Corrado Barbui +12 more
TL;DR: Clinically important differences exist between commonly prescribed antidepressants for both efficacy and acceptability in favour of escitalopram and sertraline, which might be the best choice when starting treatment for moderate to severe major depression in adults.
Journal ArticleDOI
Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis
TL;DR: A systematic overview and meta-analysis of randomised controlled trials and observational studies for the efficacy and safety of electroconvulsive therapy with simulated ECT, ECT versus pharmacotherapy, and different forms of ECT for patients with depressive illness found ECT is an effective short-term treatment for depression.